Search
Displaying results 11 - 13 of 13 in total
Tofacitinib
go.drugbank.com/drugs/DB08895ApprovedInvestigationalTofacitinib is an inhibitor of Janus kinases, a group of intracellular enzymes involved in signalling pathways that affect hematopoiesis and immune cell function. It is approved by the FDA for treatment of moderate to severe rheumatoid a...
Daclizumab
go.drugbank.com/drugs/DB00111ApprovedInvestigationalWithdrawnproduct Zenapax (daclizumab), as indicated for the prophylaxis of acute organ rejection in de novo allogeneic renal transplantation and used concomitantly with an immunosuppressive regimen like cyclosporine
Ustekinumab
go.drugbank.com/drugs/DB05679ApprovedInvestigationalUstekinumab is a fully human immunoglobulin G1 kappa monoclonal antibody that binds the shared p40 subunit of interleukin (IL)-12 and IL-23. It is used to treat plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colit...